Showing 71-80 of 80 results for "".
- Regeneron Expects FDA Decision on High-Dose Aflibercept in Third Quarterhttps://modernod.com/news/regeneron-expects-fda-decision-on-high-dose-eylea-in-third-quarter/2481766/During its second quarter conference call, Regeneron said it anticipates the FDA will take action on its biologics license application (BLA) for high-dose aflibercept during the third quarter. In June, citing "an ongoing review of inspection findings at a third-party filler,"
- FDA Does Not Approve Regeneron's High-Dose Aflibercepthttps://modernod.com/news/fda-does-not-approve-regenerons-high-dose-aflibercept/2481695/Citing "an ongoing review of inspection findings at a third-party filler," the FDA declined to approve Regeneron's aflibercept 8 mg for the treatment of patients with wet age-related macular degeneration (AMD), diabetic macular edema (DME), and diabetic retinopathy (DR).</
- Clearside Biomedical Announces Positive 6-Month Results from OASIS Extension Study with Suprachoroidal CLS-AX in Wet AMDhttps://modernod.com/news/clearside-biomedical-announces-positive-6-month-results-from-oasis-extension-study-with-suprachoroidal-cls-ax-in-wet-amd/2481380/Clearside Biomedical announced positive results from the extension study of its OASIS phase 1/2a clinical trial of CLS-AX (axitinib injectable suspension) administered by suprachoroidal injection via Clearside’s SCS Microinjector in wet age-related macular degeneration (AMD) parti
- 1-800 Contacts Announces New Company Focused on B2B Vision Technologies and Serviceshttps://modernod.com/news/1-800-contacts-announces-new-company-focused-on-b2b-vision-technologies-and-services/2480662/1-800 Contacts recently announced the formation of a standalone business, Luna Solutions, focused on providing technology and services to third parties in the vision space. The company offers 20 integrated technologies and services–ranging from telehealth platforms for n
- CoFi Announces 300 Eye Care Practices Now Use CoFi’s Compliant Co-Management Payments Tool for Ophthalmology Procedureshttps://modernod.com/news/cofi-announces-300-eye-care-practices-now-use-cofis-compliant-co-management-payments-tool-for-ophthalmology-procedures/2480490/CoFi, a provider of a multi-party payments platform for elective medical procedures, announced the growing adoption of its co-management payment solution for ophthalmology procedures with more than 300 practices now using CoFi. Throughout ophthalmology, there i
- EyeTech Digital Systems Releases the EyeOn Open Eye-Tracking Platformhttps://modernod.com/news/eyetech-digital-systems-releases-the-eyeon-open-eye-tracking-platform/2479214/EyeTech Digital Systems announced the release of its software ecosystem for the EyeOn family of eye-tracking tablets. Software-agnostic EyeOn devices support EyeTech’s applications as well as third-party applications, arming engineers and end users with the highest reliability and lowest in
- Modernizing Medicine Introduces Modmed SynapSYS Development Platformhttps://modernod.com/news/modernizing-medicine-introduces-modmed-synapsys-development-platform/2479520/Modernizing Medicine has introduced modmed synapSYS, a new app development platform and suite of application programming interfaces (APIs). Modmed synapSYS was designed to allow third-party providers, healthcare institutions, and the developer community to easily interface Modernizing Medicine te
- AbbVie Enters Deal to Develop Antibody Therapeutic for COVID-19https://modernod.com/news/abbvie-enters-deal-to-develop-antibody-therapeutic-for-covid-19/2477869/AbbVie entered into a collaboration with Harbour BioMed, Utrecht University, and Erasmus Medical Center to develop an antibody therapeutic to prevent and treat COVID-19, the parties announced Friday. The fully human, neutralising antibody 47D11, which targets the conserved domain of the spike pro
- OD-OS Introduces the Navilas expertLibrary Forum for Retina Specialistshttps://modernod.com/news/od-os-introduces-the-navilas-expertlibrary-forum-for-retina-specialists/2480093/OD-OS has introduced a new forum for retina specialists – the Navilas expertLibrary. The Navilas expertLibrary is an exclusive forum where leading retinal physicians share their day-to-day experience with this novel navigated retinal laser technology, according to OD-OS. Interested parties
- Mark Kontoshttps://modernod.com/profiles/mark-kontos/jRVYwx/
- Previous
- Next